DK0951287T3 - Oral sammensætning omfattende 5-aminosalicylsyre - Google Patents

Oral sammensætning omfattende 5-aminosalicylsyre

Info

Publication number
DK0951287T3
DK0951287T3 DK97918973T DK97918973T DK0951287T3 DK 0951287 T3 DK0951287 T3 DK 0951287T3 DK 97918973 T DK97918973 T DK 97918973T DK 97918973 T DK97918973 T DK 97918973T DK 0951287 T3 DK0951287 T3 DK 0951287T3
Authority
DK
Denmark
Prior art keywords
oral
ulcers
salicylic acid
oral composition
disease
Prior art date
Application number
DK97918973T
Other languages
English (en)
Inventor
Thomas Buser
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Application granted granted Critical
Publication of DK0951287T3 publication Critical patent/DK0951287T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK97918973T 1996-08-13 1997-08-12 Oral sammensætning omfattende 5-aminosalicylsyre DK0951287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9617001.4A GB9617001D0 (en) 1996-08-13 1996-08-13 Oral composition
PCT/EP1997/004376 WO1998006387A2 (en) 1996-08-13 1997-08-12 Oral composition comprising 5-aminosalicylic acid

Publications (1)

Publication Number Publication Date
DK0951287T3 true DK0951287T3 (da) 2002-12-09

Family

ID=10798432

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918973T DK0951287T3 (da) 1996-08-13 1997-08-12 Oral sammensætning omfattende 5-aminosalicylsyre

Country Status (12)

Country Link
US (1) US6217897B1 (da)
EP (1) EP0951287B1 (da)
JP (1) JP4597273B2 (da)
AT (1) ATE227131T1 (da)
AU (1) AU4298597A (da)
CA (1) CA2263070C (da)
DE (1) DE69716947T2 (da)
DK (1) DK0951287T3 (da)
ES (1) ES2188933T3 (da)
GB (1) GB9617001D0 (da)
PT (1) PT951287E (da)
WO (1) WO1998006387A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
HUP0303930A3 (en) * 2001-01-26 2012-09-28 Univ Emory Methods of inducing organ transplant tolerance and correcting hemoglobinopathies
MXPA04007655A (es) * 2002-02-08 2004-11-10 Johnson & Johnson Gmbh Composiciones que contienen extracto de paja de avena y de camenerio.
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
IE20070129A1 (en) * 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
UA105037C2 (uk) 2009-02-16 2014-04-10 Джуліані Інтернешнл Лімітед Способи лікування патологічних станів, пов'язаних з волоссям
US20140030354A1 (en) * 2011-03-09 2014-01-30 Paul F. Reid Composition and method for oral delivery of cobra venom
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
NZ631049A (en) 2012-04-18 2017-02-24 Nogra Pharma Ltd Methods of treating lactose intolerance
CN102697937A (zh) * 2012-06-28 2012-10-03 王佳丽 一种治疗口腔溃疡的药物及其制备方法
RU2540493C1 (ru) * 2013-12-10 2015-02-10 Гюзель Маратовна Акмалова Способ местного лечения красного плоского лишая слизистой оболочки полости рта типичной формы
MX2021009498A (es) 2019-02-08 2021-09-08 Nogra Pharma Ltd Proceso de elaboracion de acido 3-(4'-aminofenil)-2-metoxipropioni co y analogos e intermediarios del mismo.
CN113350277A (zh) * 2021-06-30 2021-09-07 广东科伦药业有限公司 一种治疗化疗口腔黏膜炎的美沙拉秦含漱液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68919009T2 (de) * 1988-05-05 1995-02-23 Tillotts Pharma Ag Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
DK254289D0 (da) 1989-05-25 1989-05-25 Dumex Ltd As Middel til behandling af svampeinfektioner
US5262164A (en) 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
NL9000237A (nl) * 1990-01-31 1991-08-16 Re Novative Drugs For Dermatol Topicale farmaceutische composities voor de mondholte en vagina.
WO1995026715A2 (en) * 1994-03-30 1995-10-12 Dumex-Alpharma A/S Use of fatty acid esters as bioadhesive substances

Also Published As

Publication number Publication date
US6217897B1 (en) 2001-04-17
CA2263070A1 (en) 1998-02-19
EP0951287A2 (en) 1999-10-27
WO1998006387A3 (en) 1998-03-19
JP2000516227A (ja) 2000-12-05
WO1998006387A2 (en) 1998-02-19
AU4298597A (en) 1998-03-06
ATE227131T1 (de) 2002-11-15
CA2263070C (en) 2009-09-08
DE69716947T2 (de) 2003-07-17
PT951287E (pt) 2003-03-31
EP0951287B1 (en) 2002-11-06
GB9617001D0 (en) 1996-09-25
JP4597273B2 (ja) 2010-12-15
ES2188933T3 (es) 2003-07-01
DE69716947D1 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
DK0951287T3 (da) Oral sammensætning omfattende 5-aminosalicylsyre
HUP0301121A2 (hu) Külsżleges gyógyszerkészítmények és gyógykezelések
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
IL154693A (en) Use of testosterone gel to make a remedy for testosterone deficiency in women
EP0282316A3 (en) Wound dressings in sheet or gelled paste form
JPS57171912A (en) Cream
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
IT1275556B (it) Procedimento ed impianto per la disidratazione di foraggio, particolarmente per la disidratazione dell'erba medica
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
EP0094714A3 (en) Gel-like calcium salt of 1-hydroxy-3-aminopropane-1,1-diphosphonic acid
NZ336600A (en) Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation
BR8803821A (pt) Metodo e composicao para a liberacao ativada a umidade e transporte no solo de um agente biologicamente ativo
DE69513109T2 (de) Holunder enthaltendes Hautpflegemittel
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
FI970165A (fi) (S)-atenosyyli-L-metioniinin (SAMe) ja sen fysiologisesti hyväksyttävien suolojen käyttö tilapäisen fokaalisen iskemian aiheuttamien reperfuusiovammojen hoitamiseksi
ATE97812T1 (de) Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
IE34883L (en) Treatment of marek's disease with ureidodiphenyl sulfone
UA885A1 (uk) Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї
SE9001963L (sv) Foerfarande foer framstaellning av en polyakrylatgel
BG103987A (en) Means for the treatment of haemorrhoids and varicose veins
RU96100994A (ru) Лечебно-косметическое средство
Dutt The Treatment of Carbuncle in the Out-Patient Department
BE829833A (fr) Abrasif filliforme
RU94021279A (ru) Препарат для лечения и профилактики мастита крупного рогатого скота